US EditionPublished • loading... • Updated
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
Investors who bought Jasper Therapeutics securities from Nov 30, 2023 to Jul 3, 2025 may seek compensation by Nov 18 lead plaintiff deadline, Rosen Law Firm said.
- Rosen Law Firm on Nov. 18, 2025, reminded Jasper Therapeutics investors that the lead-plaintiff deadline is November 18, 2025, for securities bought between Nov. 30, 2023, and July 3, 2025.
- According to the complaint, Jasper Therapeutics, Inc. lacked controls to ensure third-party manufacturers followed cGMP, risking briquilimab's trials and investor damages.
- Known for past recoveries, The Rosen Law Firm, P.A. highlighted its $438 million recovery in 2019 and top-four ISS Securities Class Action Services ranking since 2013.
- To join the Jasper Therapeutics class action, submit a form on Rosen's site or call Phillip Kim, Esq., with contact info at 866-767-3653, before November 18, 2025.
- Rosen cautioned that many notice-issuing firms lack litigation experience and urged investors to select qualified counsel, noting that past results do not guarantee similar outcomes.
Insights by Ground AI
15 Articles
15 Articles
Coverage Details
Total News Sources15
Leaning Left0Leaning Right2Center8Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
C 80%
R 20%
Factuality
To view factuality data please Upgrade to Premium
